EP Patent

EP0780127A1 — A nasal spray containing a steroid and a antihistamine

Assigned to Procter and Gamble Co · Expires 1997-06-25 · 29y expired

What this patent protects

The present invention relates to novel nasal spray compositions comprising a safe and effective amount of a glucocorticosteroid and an antihistamine possessing leukotriene inhibiting properties.

USPTO Abstract

The present invention relates to novel nasal spray compositions comprising a safe and effective amount of a glucocorticosteroid and an antihistamine possessing leukotriene inhibiting properties.

Drugs covered by this patent

naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.

Patent Metadata

Patent number: EP0780127A1
Jurisdiction: EP
Classification: —
Expires: 1997-06-25
Drug substance claim: No
Drug product claim: No
Assignee: Procter and Gamble Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.